ATE539747T1 - Verfahren und medikamente zur verabreichung von ibuprofen - Google Patents
Verfahren und medikamente zur verabreichung von ibuprofenInfo
- Publication number
- ATE539747T1 ATE539747T1 AT07813027T AT07813027T ATE539747T1 AT E539747 T1 ATE539747 T1 AT E539747T1 AT 07813027 T AT07813027 T AT 07813027T AT 07813027 T AT07813027 T AT 07813027T AT E539747 T1 ATE539747 T1 AT E539747T1
- Authority
- AT
- Austria
- Prior art keywords
- ibuprofen
- administration
- medication
- effective amount
- therapeutically effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/489,269 US20080021078A1 (en) | 2006-07-18 | 2006-07-18 | Methods and medicaments for administration of ibuprofen |
| US11/489,272 US20080020040A1 (en) | 2006-07-18 | 2006-07-18 | Unit dose form for administration of ibuprofen |
| US89737107P | 2007-01-24 | 2007-01-24 | |
| PCT/US2007/073716 WO2008011426A2 (en) | 2006-07-18 | 2007-07-17 | Methods and medicaments for administration of ibuprofen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE539747T1 true ATE539747T1 (de) | 2012-01-15 |
Family
ID=38957561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07813027T ATE539747T1 (de) | 2006-07-18 | 2007-07-17 | Verfahren und medikamente zur verabreichung von ibuprofen |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP2438919A1 (OSRAM) |
| JP (1) | JP2009543885A (OSRAM) |
| AT (1) | ATE539747T1 (OSRAM) |
| AU (1) | AU2007275360B2 (OSRAM) |
| BR (1) | BRPI0714937A2 (OSRAM) |
| CA (1) | CA2657928C (OSRAM) |
| DK (1) | DK2043637T3 (OSRAM) |
| ES (1) | ES2380747T3 (OSRAM) |
| IL (1) | IL196425A (OSRAM) |
| NZ (1) | NZ574200A (OSRAM) |
| PL (1) | PL2043637T3 (OSRAM) |
| PT (1) | PT2043637E (OSRAM) |
| WO (1) | WO2008011426A2 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| WO2008091957A2 (en) * | 2007-01-24 | 2008-07-31 | Horizon Therapeutics, Inc. | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| WO2013054352A1 (en) | 2011-08-17 | 2013-04-18 | Cadila Healthcare Limited | Pharmaceutical compositions of ibuprofen and famotidine |
| CA2889711A1 (en) | 2012-10-29 | 2014-05-08 | Arizona Board Of Regents On Behalf Of University Of Arizona | Predictive markers for polyamine inhibitor cancer therapies |
| WO2015163832A1 (en) | 2014-04-25 | 2015-10-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | An ibuprofen and famotidine combined composition having improved stability |
| US10655183B2 (en) | 2014-06-18 | 2020-05-19 | Arizona Board Of Regents On Behalf Of University Of Arizona | Carcinoma diagnosis and treatment based on ODC1 genotype |
| WO2017075576A1 (en) * | 2015-10-30 | 2017-05-04 | Cancer Prevention Pharmaceuticals, Inc. | Eflornithine and sulindac, fixed dose combination formulation |
| MA43114A (fr) | 2015-10-30 | 2018-09-05 | Cancer Prevention Pharmaceuticals Inc | Formulation combinée à dose fixe d'éflornithine et sulindac |
| US10945981B2 (en) | 2019-05-17 | 2021-03-16 | Cancer Prevention Pharmaceuticals, Inc. | Methods for treating familial adenomatous polyposis |
| US11324727B2 (en) | 2020-07-15 | 2022-05-10 | Schabar Research Associates, Llc | Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn |
| IL299845A (en) * | 2020-07-15 | 2023-03-01 | Schabar Res Associates Llc | Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn |
| CN117320697A (zh) * | 2021-10-21 | 2023-12-29 | 韩和制药株式会社 | 包含孟鲁司特或其药学上可接受的盐和左西替利嗪或其药学上可接受的盐的稳定性提高的薄膜包衣片剂 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| US4543370A (en) | 1979-11-29 | 1985-09-24 | Colorcon, Inc. | Dry edible film coating composition, method and coating form |
| US4802924A (en) | 1986-06-19 | 1989-02-07 | Colorcon, Inc. | Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products |
| HU196775B (en) | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
| EP0663839A4 (en) * | 1992-09-29 | 1998-06-03 | Merck & Co Inc | Ibuprofen-h 2? antagonist combinations. |
| US5976578A (en) * | 1996-10-10 | 1999-11-02 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
| US6251945B1 (en) | 1999-01-14 | 2001-06-26 | Knoll Aktiengesellschaft | Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| DE10003757A1 (de) | 2000-01-28 | 2001-08-02 | Knoll Ag | Ibuprofen-Wirkstoffzubereitung |
| ES2348710T5 (es) * | 2001-06-01 | 2014-02-17 | Pozen, Inc. | Composiciones farmacéuticas para el suministro coordinado de NSAID |
| DE10153934A1 (de) | 2001-11-06 | 2003-05-22 | Basf Ag | Verfahren zur Kristallisation von Profenen |
| WO2004064815A1 (en) * | 2003-01-21 | 2004-08-05 | Smartrix Technologies Inc. | Oral dosage formulation |
| JP2006076956A (ja) * | 2004-09-10 | 2006-03-23 | Taiyo Yakuhin Kogyo Kk | 胃炎の治療・予防用配合剤 |
| US20070043096A1 (en) | 2005-07-18 | 2007-02-22 | Horizon Therapeutics, Inc. | Unit dose form with ibuprofen-famotidine admixture |
| DE102005049001A1 (de) | 2005-10-11 | 2007-04-12 | Basf Ag | Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen |
-
2007
- 2007-07-17 BR BRPI0714937-9A patent/BRPI0714937A2/pt not_active Application Discontinuation
- 2007-07-17 JP JP2009520962A patent/JP2009543885A/ja active Pending
- 2007-07-17 EP EP12150096A patent/EP2438919A1/en not_active Withdrawn
- 2007-07-17 ES ES07813027T patent/ES2380747T3/es active Active
- 2007-07-17 EP EP07813027A patent/EP2043637B8/en not_active Not-in-force
- 2007-07-17 DK DK07813027.5T patent/DK2043637T3/da active
- 2007-07-17 CA CA2657928A patent/CA2657928C/en not_active Expired - Fee Related
- 2007-07-17 AU AU2007275360A patent/AU2007275360B2/en not_active Ceased
- 2007-07-17 PL PL07813027T patent/PL2043637T3/pl unknown
- 2007-07-17 WO PCT/US2007/073716 patent/WO2008011426A2/en not_active Ceased
- 2007-07-17 NZ NZ574200A patent/NZ574200A/en not_active IP Right Cessation
- 2007-07-17 AT AT07813027T patent/ATE539747T1/de active
- 2007-07-17 PT PT07813027T patent/PT2043637E/pt unknown
-
2009
- 2009-01-11 IL IL196425A patent/IL196425A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| PT2043637E (pt) | 2012-04-12 |
| EP2043637B1 (en) | 2012-01-04 |
| DK2043637T3 (da) | 2012-05-07 |
| WO2008011426A2 (en) | 2008-01-24 |
| IL196425A (en) | 2014-07-31 |
| CA2657928C (en) | 2014-12-02 |
| EP2438919A1 (en) | 2012-04-11 |
| IL196425A0 (en) | 2009-11-18 |
| JP2009543885A (ja) | 2009-12-10 |
| EP2043637B8 (en) | 2012-03-28 |
| AU2007275360A1 (en) | 2008-01-24 |
| PL2043637T3 (pl) | 2012-06-29 |
| NZ574200A (en) | 2011-02-25 |
| AU2007275360B2 (en) | 2013-05-16 |
| WO2008011426A3 (en) | 2008-12-04 |
| CA2657928A1 (en) | 2008-01-24 |
| EP2043637A4 (en) | 2009-11-25 |
| BRPI0714937A2 (pt) | 2013-03-26 |
| EP2043637A2 (en) | 2009-04-08 |
| ES2380747T3 (es) | 2012-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE539747T1 (de) | Verfahren und medikamente zur verabreichung von ibuprofen | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| CY1116727T1 (el) | Θεραπεια πολλαπλης σκληρυνσης me laquinimod | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| FR15C0009I2 (fr) | Compositions de gel phospholipide destinees a l'administration medicamenteuse et des methodes de traitement utilisant celles-ci | |
| EA201491285A1 (ru) | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| EP2296734A4 (en) | DEVICE AND METHOD FOR DELIVERING A DENTAL COMPOSITION | |
| DE602007007991D1 (de) | Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung | |
| MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
| WO2008027350A3 (en) | Acetaminophen pharmaceutical compositions | |
| EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
| WO2007098479A3 (en) | Localized insulin delivery for bone healing | |
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| EA201270071A1 (ru) | Способ лечения пациента, нуждающегося в аспириновой терапии | |
| ATE513562T1 (de) | Nicht-spezifische immunstimulierende mittel | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| SE0400184D0 (sv) | New therapeutical use | |
| ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
| EA200702522A1 (ru) | Система доставки лекарств в полость рта и способы ее применения | |
| EA201170108A1 (ru) | Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки | |
| DE602007014193D1 (de) | Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon | |
| ATE466574T1 (de) | Verfahren und zusammensetzungen zur oralen fts- abgabe | |
| WO2007144889A3 (en) | Treatment of neurofibromatosis | |
| EA200801388A1 (ru) | Фармацевтическая композиция для лечения туберкулеза и заболеваний, опосредованных helicobacter pilory, на основе полимерных наночастиц, способ ее получения и способ лечения |